JP2017512762A5 - - Google Patents

Download PDF

Info

Publication number
JP2017512762A5
JP2017512762A5 JP2016555478A JP2016555478A JP2017512762A5 JP 2017512762 A5 JP2017512762 A5 JP 2017512762A5 JP 2016555478 A JP2016555478 A JP 2016555478A JP 2016555478 A JP2016555478 A JP 2016555478A JP 2017512762 A5 JP2017512762 A5 JP 2017512762A5
Authority
JP
Japan
Prior art keywords
hexafluorophosphate
acid
compound
hydrogen
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016555478A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017512762A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/072267 external-priority patent/WO2015134096A1/en
Publication of JP2017512762A publication Critical patent/JP2017512762A/ja
Publication of JP2017512762A5 publication Critical patent/JP2017512762A5/ja
Pending legal-status Critical Current

Links

JP2016555478A 2014-03-03 2014-12-23 薬学的に妥当な芳香族カチオン性ペプチド及びその生成方法 Pending JP2017512762A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461947286P 2014-03-03 2014-03-03
US61/947,286 2014-03-03
PCT/US2014/072267 WO2015134096A1 (en) 2014-03-03 2014-12-23 Pharmaceutically relevant aromatic-cationic peptides

Publications (2)

Publication Number Publication Date
JP2017512762A JP2017512762A (ja) 2017-05-25
JP2017512762A5 true JP2017512762A5 (https=) 2018-02-08

Family

ID=54055710

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016555478A Pending JP2017512762A (ja) 2014-03-03 2014-12-23 薬学的に妥当な芳香族カチオン性ペプチド及びその生成方法

Country Status (7)

Country Link
US (1) US20170081363A1 (https=)
EP (1) EP3114136A4 (https=)
JP (1) JP2017512762A (https=)
CN (1) CN106459169A (https=)
CA (1) CA2942143A1 (https=)
HK (1) HK1231493A1 (https=)
WO (1) WO2015134096A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6626446B2 (ja) * 2013-12-27 2019-12-25 ステルス バイオセラピューティックス コープ 薬学的に適切な芳香族カチオン性ペプチド
US10633415B2 (en) 2015-03-06 2020-04-28 Stealth Biotherapeutics Corp Processes for preparing pharmaceutically relevant peptides
JPWO2017043626A1 (ja) * 2015-09-11 2018-06-21 株式会社カネカ 光学活性4−カルバモイル−2,6−ジメチルフェニルアラニン誘導体の製造法
CA3020393A1 (en) 2016-04-11 2017-10-19 Carnot, Llc Chiral peptides
CN110914287A (zh) 2017-04-05 2020-03-24 隐形生物治疗公司 Boc-d-arg-dmt-lys-(boc)-phe-nh2的结晶盐形式
US20200361987A1 (en) * 2017-11-15 2020-11-19 Stealth Biotherapeutics Corp. Deuterated tetrapeptides that target mitochondria
US10676506B2 (en) 2018-01-26 2020-06-09 Stealth Biotherapeutics Corp. Crystalline bis- and tris-hydrochloride salt of elamipretide
EP3898653A4 (en) 2018-12-18 2022-08-24 Stealth BioTherapeutics Inc. ANALOGS TARGETING MITOCHONDRIAL DISEASES
TW202346255A (zh) * 2022-01-06 2023-12-01 日商中外製藥股份有限公司 醯胺化合物的製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214663B2 (en) * 2000-06-14 2007-05-08 Medarex, Inc. Tripeptide prodrug compounds
JP4879020B2 (ja) * 2003-05-01 2012-02-15 コーネル リサーチ ファウンデイション インコーポレイテッド 細胞に分子を送達する方法及び担体複合体
US20070213505A1 (en) * 2006-03-08 2007-09-13 David Epstein Solution Synthesis of Peptide Cell Growth Stimulators
EP3375449A1 (en) * 2010-03-15 2018-09-19 Stealth Peptides International, Inc. Combination therapies using cyclosporine and aromatic cationic peptides
AU2012271691A1 (en) * 2011-06-14 2014-01-16 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
HK1204988A1 (en) * 2012-02-22 2015-12-11 Stealth Peptides International, Inc. Methods and compositions for preventing or treating ophthalmic conditions
EP2928562A4 (en) * 2012-12-06 2016-06-22 Stealth Peptides Int Inc PEPTIDE THERAPEUTIC PRODUCTS AND METHODS OF USE

Similar Documents

Publication Publication Date Title
JP2017512762A5 (https=)
JP2017502956A5 (https=)
ES2552338T3 (es) Compuestos farmacéuticos
KR102371784B1 (ko) 활성화 혈액 응고 제 X 인자 (FXa) 의 저해약의 제조 방법
JP7450572B2 (ja) 薬学的に適切なペプチドを調製するための方法
EP3645529B1 (en) Process for preparing lifitegrast and intermediates thereof
AU2008346833A1 (en) Process for preparing N-substituted hydroxypyrimidinone carboxamides
KR101949551B1 (ko) 벤족사지논을 아민과 반응시켜 테트라졸-치환된 안트라닐산 디아미드 유도체를 제조하는 방법
JP2016535081A5 (https=)
CA2801101A1 (en) Process for preparing a biphenyl-2-ylcarbamic acid
CA3183040A1 (en) Processes for the preparation of an apoptosis-inducing agent
ES2715082T3 (es) Método de producción de un pentapéptido sintético
JP2017512762A (ja) 薬学的に妥当な芳香族カチオン性ペプチド及びその生成方法
WO2020096042A1 (ja) ジメトキシベンゼン化合物の製造方法
CN107810189B (zh) 用于制备氮芥衍生物的方法
ES2791187T3 (es) Síntesis de dabigatrán
CN107848987A (zh) 含氮杂环化合物的制造方法及其中间体
KR20150067175A (ko) 보르테조밉을 제조하기 위한 방법
KR101578979B1 (ko) 라코사마이드의 제조방법
KR20210088651A (ko) 디메톡시벤젠 화합물의 제조 방법
ES2827459T3 (es) Procedimiento para la preparación de apixaban
US10329325B2 (en) Process for the preparation of (S)-4-methyl-N-((S)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxo-pentan-2-yl) amino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido) pentanamide
US20240002432A1 (en) Method for producing amino acid or peptide, protective group-forming reagent, and compound
JP2015501324A (ja) アシルグアニジン及びアシルチオ尿素の新規調製方法
KR102702677B1 (ko) 피마살탄 및 그의 제조 중간체의 제조방법